Trial intelligence / Profile preview

Capecitabine with concomitant radiation therapy in children with newly diagnosed brainstem gliomas

2016-001045-12Phase 2

Sponsor
Roche
Start
Jul 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of capecitabine in brainstem glioma, diffuse intrinsic brainstem glioma (DIPG), sponsored by Roche.

02

Drugs

capecitabine
03

Conditions

brainstem gliomadiffuse intrinsic brainstem glioma (DIPG)

Beyond the preview

Go deeper on 2016-001045-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001045-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call